Yue Xi

3.2k total citations · 1 hit paper
30 papers, 2.0k citations indexed

About

Yue Xi is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Yue Xi has authored 30 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Epidemiology. Recurrent topics in Yue Xi's work include Liver Disease Diagnosis and Treatment (7 papers), Copper-based nanomaterials and applications (4 papers) and Natural Compounds in Disease Treatment (4 papers). Yue Xi is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Copper-based nanomaterials and applications (4 papers) and Natural Compounds in Disease Treatment (4 papers). Yue Xi collaborates with scholars based in China, United States and Macao. Yue Xi's co-authors include Pengfei Xu, Zhiying Huang, Qunzeng Huang, Pengfei Ye, Yike Li, Yunhui Zhang, Sirui Zhu, Feihai Shen, Haiquan Xie and Songrong Ren and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Hepatology.

In The Last Decade

Yue Xi

28 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global colorectal cancer burden in 2020 and projections to 2040

2021 1.5k citations Yue Xi, Pengfei Xu Translational Oncology profile →

Peers

Countries citing papers authored by Yue Xi

Since Specialization

Citations

This map shows the geographic impact of Yue Xi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yue Xi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yue Xi more than expected).

Fields of papers citing papers by Yue Xi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yue Xi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yue Xi. The network helps show where Yue Xi may publish in the future.

Co-authorship network of co-authors of Yue Xi

This figure shows the co-authorship network connecting the top 25 collaborators of Yue Xi. A scholar is included among the top collaborators of Yue Xi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yue Xi. Yue Xi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Targeting ADAR1-mediated RNA editing inhibits hepatic stellate cell activation and liver fibrosis by enhancing HSC-intrinsic innate immunity	Gut	Yue Xi, Lingyi Liu et al.	0
2	Treatment of 5-fluorouracil-induced chemotherapeutic intestinal mucositis in mice by oral inulin via glycerophospholipid and retinol metabolic pathways	ScienceAsia	Yue Xi, Jiajun Tan et al.	0
3	The desulfinylation enzyme sulfiredoxin-1 attenuates HSC activation and liver fibrosis by modulating the PTPN12-NLRP3 axis	Hepatology	Mengyun Ke, Pengfei Xu et al.	2
4	Themis: advancing precision oncology through comprehensive molecular subtyping and optimization	Briefings in Bioinformatics	Yue Xi, Kun Zheng et al.	2
5	Single-cell technology for drug discovery and development	SHILAP Revista de lepidopterología	A Zhang, Jiawei Zou et al.	2
6	Mapping the gut microbial structural variations in healthy aging within the Chinese population	Cell Reports	Luqi Shen, Yue Xi et al.	2
7	Visualization research on ENT1/NIS dual-function gene therapy to reverse drug resistance mediated by MUC1 in GEM-resistant pancreatic cancer	Nuclear Medicine and Biology	Yun Xi, Hong Chen et al.	1
8	A chemotherapy response prediction model derived from tumor-promoting B and Tregs and proinflammatory macrophages in HGSOC	Frontiers in Oncology	Yue Xi, Yingchun Zhang et al.	6
9	Risk prediction model construction for post myocardial infarction heart failure by blood immune B cells	Frontiers in Immunology	Jie Hao, Yue Xi et al.	2
10	Sulfation of chondroitin and bile acids converges to antagonize Wnt/β-catenin signaling and inhibit APC deficiency-induced gut tumorigenesis	Acta Pharmaceutica Sinica B	Pengfei Xu, Yue Xi et al.	7
11	Bone Marrow Mesenchymal Stem Cell-Mediated Radiosensitive Promoter-Combined Sodium Iodide Symporter for the Treatment of Breast Cancer	Human Gene Therapy	Lu Zhang, Yue Xi et al.	1
12	Prognostic value of circulating tumor cells and analysis of clinicopathological factors in liver cancer	Journal of Cancer Research and Therapeutics	Kai Cui, Yang Ou et al.	1
13	Inhibition of p53 Sulfoconjugation Prevents Oxidative Hepatotoxicity and Acute Liver Failure	Gastroenterology	Pengfei Xu, Yue Xi et al.	25
14	Intestinal Sulfation Is Essential to Protect Against Colitis and Colonic Carcinogenesis	Gastroenterology	Pengfei Xu, Yue Xi et al.	42
15	The anti-fibrotic drug pirfenidone inhibits liver fibrosis by targeting the small oxidoreductase glutaredoxin-1	Science Advances	Yue Xi, Yanping Li et al.	50
16	Global colorectal cancer burden in 2020 and projections to 2040 breakdown →	Translational Oncology	Yue Xi, Pengfei Xu	1461
17	Therapeutic potentials of fasudil in liver fibrosis	World Journal of Gastroenterology	Yue Xi, Pengfei Xu	4
18	Triptolide induces oxidative damage in NRK-52E cells through facilitating Nrf2 degradation by ubiquitination via the GSK-3β/Fyn pathway	Toxicology in Vitro	Feihai Shen, Yue Xi et al.	22
19	Triptolide induces p53-dependent cardiotoxicity through mitochondrial membrane permeabilization in cardiomyocytes	Toxicology and Applied Pharmacology	Yue Xi, Wenwen Wang et al.	29
20	Triptolide-induced mitochondrial damage dysregulates fatty acid metabolism in mouse sertoli cells	Toxicology Letters	Gaojian Chen, Li Wang et al.	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact